Publication|Articles|May 28, 2026
Supplements and Featured Publications
- Long-Term Real-World Economic and Clinical Outcomes of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Cystic Fibrosis
Long-Term Real-World Economic and Clinical Outcomes of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Cystic Fibrosis
Advertisement
This Clinical Brief was sponsored by Vertex Pharmaceuticals Incorporated.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
DOJ Abandons Olmstead Defense as Texas v Kennedy Advances
2
FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes
3
Myasthenia Gravis Linked to Greater Longevity Than Multiple Sclerosis
4
FDA Approves Rusfertide to Treat Erythrocytosis In Polycythemia Vera
5